-
Je něco špatně v tomto záznamu ?
Mitochondrial Dysfunction in Blood Platelets of Patients with Manic Episode of Bipolar Disorder
J. Hroudová, Z. Fišar, H. Hansíková, L. Kališová, E. Kitzlerová, M. Zvěřová, A. Lambertová, J. Raboch,
Jazyk angličtina Země Spojené arabské emiráty
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- bipolární porucha komplikace farmakoterapie metabolismus MeSH
- citrátsynthasa metabolismus MeSH
- dospělí MeSH
- elektronový transportní řetězec metabolismus MeSH
- lidé MeSH
- mitochondrie metabolismus MeSH
- trombocytopatie komplikace metabolismus MeSH
- trombocyty metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: The bipolar affective disorder (BAD) pathophysiology is multifactorial and has not been fully clarified. METHOD: We measured selected mitochondrial parameters in peripheral blood components. The analyses were performed for patients suffering from a manic episode during remission and were compared to those performed for healthy controls. BAD was clinically evaluated using well-established diagnostic scales and questionnaires. Mitochondrial respiration was examined in intact and permeabilized blood platelets using high-resolution respirometry. The citrate synthase (CS) and electron transport system (ETS) complex (complex I, II, and IV) activities were examined in platelets. RESULTS: The CS, complex II and complex IV activities were decreased in the BAD patients, complex I activity was increased, and the ratio of complex I to CS was significantly increased. In the intact platelets, respiration after complex I inhibition and residual oxygen consumption were decreased in the BAD patients compared to the healthy controls. In the permeabilized platelets, a decreased ETS capacity was found in the BAD patients. No significant differences were found between BAD patients in mania and remission. CONCLUSION: Increased complex I activity can be a compensatory mechanism for decreased CS and complex II and IV activities. We conclude that complex I and its abnormal activity contribute to defects in cellular energy metabolism during a manic episode and that the deficiency in the complex's functioning, but not the availability of oxidative phosphorylation substrates, seems to be responsible for the decreased ETS capacity in BAD patients. The observed parameters can be further evaluated as 'trait' markers of BAD.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20022928
- 003
- CZ-PrNML
- 005
- 20201214125002.0
- 007
- ta
- 008
- 201125s2019 ts f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/1871527318666181224130011 $2 doi
- 035 __
- $a (PubMed)30582486
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ts
- 100 1_
- $a Hroudová, Jana $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague 2, Czech Republic. Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Albertov 4, 128 00 Prague 2, Czech Republic.
- 245 10
- $a Mitochondrial Dysfunction in Blood Platelets of Patients with Manic Episode of Bipolar Disorder / $c J. Hroudová, Z. Fišar, H. Hansíková, L. Kališová, E. Kitzlerová, M. Zvěřová, A. Lambertová, J. Raboch,
- 520 9_
- $a OBJECTIVES: The bipolar affective disorder (BAD) pathophysiology is multifactorial and has not been fully clarified. METHOD: We measured selected mitochondrial parameters in peripheral blood components. The analyses were performed for patients suffering from a manic episode during remission and were compared to those performed for healthy controls. BAD was clinically evaluated using well-established diagnostic scales and questionnaires. Mitochondrial respiration was examined in intact and permeabilized blood platelets using high-resolution respirometry. The citrate synthase (CS) and electron transport system (ETS) complex (complex I, II, and IV) activities were examined in platelets. RESULTS: The CS, complex II and complex IV activities were decreased in the BAD patients, complex I activity was increased, and the ratio of complex I to CS was significantly increased. In the intact platelets, respiration after complex I inhibition and residual oxygen consumption were decreased in the BAD patients compared to the healthy controls. In the permeabilized platelets, a decreased ETS capacity was found in the BAD patients. No significant differences were found between BAD patients in mania and remission. CONCLUSION: Increased complex I activity can be a compensatory mechanism for decreased CS and complex II and IV activities. We conclude that complex I and its abnormal activity contribute to defects in cellular energy metabolism during a manic episode and that the deficiency in the complex's functioning, but not the availability of oxidative phosphorylation substrates, seems to be responsible for the decreased ETS capacity in BAD patients. The observed parameters can be further evaluated as 'trait' markers of BAD.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a bipolární porucha $x komplikace $x farmakoterapie $x metabolismus $7 D001714
- 650 _2
- $a trombocytopatie $x komplikace $x metabolismus $7 D001791
- 650 _2
- $a trombocyty $x metabolismus $7 D001792
- 650 _2
- $a citrátsynthasa $x metabolismus $7 D002950
- 650 _2
- $a elektronový transportní řetězec $x metabolismus $7 D045222
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fišar, Zdeněk $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague 2, Czech Republic.
- 700 1_
- $a Hansíková, Hana $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, Czech Republic.
- 700 1_
- $a Kališová, Lucie $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague 2, Czech Republic.
- 700 1_
- $a Kitzlerová, Eva $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague 2, Czech Republic.
- 700 1_
- $a Zvěřová, Martina $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague 2, Czech Republic.
- 700 1_
- $a Lambertová, Alena $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague 2, Czech Republic.
- 700 1_
- $a Raboch, Jiří $u Department of Psychiatry, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 11, 120 00 Prague 2, Czech Republic.
- 773 0_
- $w MED00173402 $t CNS & neurological disorders drug targets $x 1996-3181 $g Roč. 18, č. 3 (2019), s. 222-231
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30582486 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125002 $b ABA008
- 999 __
- $a ok $b bmc $g 1595247 $s 1113604
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 18 $c 3 $d 222-231 $e - $i 1996-3181 $m CNS & neurological disorders. Drug targets $n CNS Neurol Disord Drug Targets $x MED00173402
- LZP __
- $a Pubmed-20201125
